Used as a key intermediate in the synthesis of antifungal medications, particularly in the production of fluconazole and related triazole antifungals. Its structure allows for the formation of the core pharmacophore that targets fungal cytochrome P450 enzymes, inhibiting ergosterol biosynthesis. Commonly employed in pharmaceutical research and development for optimizing antifungal agents with improved efficacy and reduced side effects.